Tandem Investment Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$488K Sell
1,348
-194
-13% -$66.4K 0.38% 49
2026
Q1
$543K Sell
1,542
-146
-9% -$52K 0.46% 47
2025
Q4
$552K Sell
1,688
-354
-17% -$112K 0.47% 47
2025
Q3
$576K Sell
2,042
-5
-0.2% -$1.45K 0.47% 48
2025
Q2
$572K Buy
2,047
+300
+17% +$85K 0.5% 46
2025
Q1
$544K Hold
1,747
0.54% 44
2024
Q4
$455K Buy
+1,747
New +$518K 0.44% 44

Other funds holding AMGN

Tandem Investment Partners's AMGN Position: Q2 2026 in Review

Tandem Investment Partners reduced its Amgen (AMGN) stake by 13% in Q2 2026, selling an estimated $66.4K and leaving 1,348 shares worth $488K. The position accounts for 0.38% of the portfolio, ranked #49.

Tandem Investment Partners first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $576K in Q3 2025. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Tandem Investment Partners held 1,348 shares of Amgen worth $488K as of Q2 2026.
  • Tandem Investment Partners sold 194 Amgen shares in Q2 2026, an estimated $66.4K.
  • Amgen made up 0.38% of Tandem Investment Partners's portfolio in Q2 2026, its #49 holding.
  • Tandem Investment Partners first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • Tandem Investment Partners's Amgen position peaked at $576K in Q3 2025.
  • 1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Tandem Investment Partners's 13F filing for Q2 2026, filed 27 Jul 2026.